As of May 28, 2025, Guided Therapeutics Inc (GTHP) reports a Net Margin of -34528.57%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Guided Therapeutics Inc's Net Margin
Over recent years, Guided Therapeutics Inc's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-12-31 | -34528.57% |
| 2023-12-31 | -3560.20% |
| 2022-12-31 | -43400.00% |
| 2021-12-31 | -2587.50% |
| 2020-12-31 | -280.00% |
This slight downward trend highlights how Guided Therapeutics Inc manages its overall profitability and cost control over time.
Comparing Guided Therapeutics Inc's Net Margin to Peers
To better understand Guided Therapeutics Inc's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Guided Therapeutics Inc (GTHP) | -34528.57% |
| PAVmed Inc (PAVM) | 1328.58% |
| United American Healthcare Corp (UAHC) | -23.77% |
| Remedent Inc (REMI) | -80.63% |
| Paradigm Medical Industries Inc (PDMI) | -86.59% |
| Positron Corp (POSC) | -176.26% |
Compared to its competitors, Guided Therapeutics Inc's Net Margin is among the lowest compared to peers, which may indicate challenges in controlling expenses or competitive pricing pressures.